BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19454690)

  • 1. PI3K links NKG2D signaling to a CrkL pathway involved in natural killer cell adhesion, polarity, and granule secretion.
    Segovis CM; Schoon RA; Dick CJ; Nacusi LP; Leibson PJ; Billadeau DD
    J Immunol; 2009 Jun; 182(11):6933-42. PubMed ID: 19454690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JNK MAP kinase activation is required for MTOC and granule polarization in NKG2D-mediated NK cell cytotoxicity.
    Li C; Ge B; Nicotra M; Stern JN; Kopcow HD; Chen X; Strominger JL
    Proc Natl Acad Sci U S A; 2008 Feb; 105(8):3017-22. PubMed ID: 18287025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NKG2D triggers cytotoxicity in murine epidermal γδ T cells via PI3K-dependent, Syk/ZAP70-independent signaling pathway.
    Ibusuki A; Kawai K; Yoshida S; Uchida Y; Nitahara-Takeuchi A; Kuroki K; Kajikawa M; Ose T; Maenaka K; Kasahara M; Kanekura T
    J Invest Dermatol; 2014 Feb; 134(2):396-404. PubMed ID: 23962808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A signaling network stimulated by β2 integrin promotes the polarization of lytic granules in cytotoxic cells.
    Zhang M; March ME; Lane WS; Long EO
    Sci Signal; 2014 Oct; 7(346):ra96. PubMed ID: 25292215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PI3K p85 β regulatory subunit deficiency does not affect NK cell differentiation and increases NKG2D-mediated activation.
    Rojas JM; Spada R; Sanz-Ortega L; Morillas L; Mejías R; Mulens-Arias V; Pérez-Yagüe S; Barber DF
    J Leukoc Biol; 2016 Dec; 100(6):1285-1296. PubMed ID: 27381007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid activation receptor- or IL-2-induced lytic granule convergence in human natural killer cells requires Src, but not downstream signaling.
    James AM; Hsu HT; Dongre P; Uzel G; Mace EM; Banerjee PP; Orange JS
    Blood; 2013 Apr; 121(14):2627-37. PubMed ID: 23380740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Many NK cell receptors activate ERK2 and JNK1 to trigger microtubule organizing center and granule polarization and cytotoxicity.
    Chen X; Trivedi PP; Ge B; Krzewski K; Strominger JL
    Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6329-34. PubMed ID: 17395718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in Molecular Mechanisms of the NKG2D Pathway in Hepatocellular Carcinoma.
    Wang J; Li CD; Sun L
    Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32075046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rap1b facilitates NK cell functions via IQGAP1-mediated signalosomes.
    Awasthi A; Samarakoon A; Chu H; Kamalakannan R; Quilliam LA; Chrzanowska-Wodnicka M; White GC; Malarkannan S
    J Exp Med; 2010 Aug; 207(9):1923-38. PubMed ID: 20733035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NKG2D Signaling between Human NK Cells Enhances TACE-Mediated TNF-α Release.
    Sharma N; Trinidad CV; Trembath AP; Markiewicz MA
    J Immunol; 2017 Oct; 199(8):2865-2872. PubMed ID: 28893955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NKG2D-DAP10 signaling recruits EVL to the cytotoxic synapse to generate F-actin and promote NK cell cytotoxicity.
    Wilton KM; Overlee BL; Billadeau DD
    J Cell Sci; 2019 Jul; 133(5):. PubMed ID: 31235500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors.
    André P; Castriconi R; Espéli M; Anfossi N; Juarez T; Hue S; Conway H; Romagné F; Dondero A; Nanni M; Caillat-Zucman S; Raulet DH; Bottino C; Vivier E; Moretta A; Paul P
    Eur J Immunol; 2004 Apr; 34(4):961-71. PubMed ID: 15048706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity.
    Pievani A; Borleri G; Pende D; Moretta L; Rambaldi A; Golay J; Introna M
    Blood; 2011 Sep; 118(12):3301-10. PubMed ID: 21821703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cells gene-engineered with DAP12 mediate effector function in an NKG2D-dependent and major histocompatibility complex-independent manner.
    Teng MW; Kershaw MH; Hayakawa Y; Cerutti L; Jane SM; Darcy PK; Smyth MJ
    J Biol Chem; 2005 Nov; 280(46):38235-41. PubMed ID: 16169855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases.
    Zompi S; Hamerman JA; Ogasawara K; Schweighoffer E; Tybulewicz VL; Di Santo JP; Lanier LL; Colucci F
    Nat Immunol; 2003 Jun; 4(6):565-72. PubMed ID: 12740576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12.
    Girart MV; Fuertes MB; Domaica CI; Rossi LE; Zwirner NW
    J Immunol; 2007 Sep; 179(6):3472-9. PubMed ID: 17804388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells.
    Sutherland CL; Chalupny NJ; Schooley K; VandenBos T; Kubin M; Cosman D
    J Immunol; 2002 Jan; 168(2):671-9. PubMed ID: 11777960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells.
    Coudert JD; Zimmer J; Tomasello E; Cebecauer M; Colonna M; Vivier E; Held W
    Blood; 2005 Sep; 106(5):1711-7. PubMed ID: 15886320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inability of granule polarization by NK cells defines tumor resistance and can be overcome by CAR or ADCC mediated targeting.
    Eitler J; Wotschel N; Miller N; Boissel L; Klingemann HG; Wels W; Tonn T
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33468562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syk regulation of phosphoinositide 3-kinase-dependent NK cell function.
    Jiang K; Zhong B; Gilvary DL; Corliss BC; Vivier E; Hong-Geller E; Wei S; Djeu JY
    J Immunol; 2002 Apr; 168(7):3155-64. PubMed ID: 11907067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.